RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 23-33
  • Pfizer's $11 billion buyback plan deflates AstraZeneca bid hopes

    LONDON/NEW YORK (Reuters) - U.S. drugmaker Pfizer is to continue buying back stock, with the board authorizing a new $11 billion share repurchase plan, deflating expectations that it will make a new bid for AstraZeneca. Shares in AstraZeneca fell 1.2...
  • Hikma Pharma shares slip on FDA warning for Portugal plant

    (Reuters) - Drugmaker Hikma Pharmaceuticals Plc said the U.S. health regulator had raised issues related to environmental monitoring at its plant in Portugal, which some analysts said accounts for about a quarter of the company's U.S. injectibles sales....
  • How to judge Medicare plans

    How to judge Medicare plans
    While much of the nation is preoccupied with Obamacare and picking new health insurance at work, older Americans have deadlines of their own coming up — involving Medicare. We're just a few days away from the two-month period when the nation's...
  • Endo says Auxilium Pharmaceuticals has agreed to $2.6B purchase

    PHILADELPHIA Drugmaker Endo International P.L.C, run largely from Malvern, Pa., but incorporated in Ireland, said Thursday that it has convinced directors of Auxilium Pharmaceuticals, a Chesterbrook, Pa.-based maker of testosterone-replacement...
  • Ebola scams spreading as fears mount

    Ebola scams spreading as fears mount
    I can't tell you whether to believe assurances from those in power that the deadly Ebola virus will be kept in check, but there's no doubt that panicking can expose you to harm. Scams related to the Ebola outbreak are spreading and you aren't immune....
  • AbbVie says tax rule changes scuttled deal for Shire

     AbbVie says tax rule changes scuttled deal for Shire
    AbbVie is blaming the Obama administration for pulling the plug on its $55 billion proposed acquisition of Irish drugmaker Shire, asserting that the largest corporate deal of the year no longer made economic sense under new federal tax regulations. Late...
  • Durbin hopes tide turning against corporate inversions

    WASHINGTON Senate Majority Whip Richard J. Durbin, D-Ill., is hoping the tide is turning against corporate inversions a practice aimed at minimizing U.S. taxes by merging with overseas firms. After taking to the Senate floor to shame Chicago-based...
  • Beware: Some Medicare Advantage plans have plenty of disadvantages

    CHICAGO (Reuters) - Seniors have flocked to Medicare Advantage in recent years, attracted by savings on premiums and the convenience of one-stop shopping. But as the annual Medicare enrollment season began this week, a memorandum from federal officials to...
  • AbbVie board calls off Shire acquisition

    AbbVie board calls off Shire acquisition
    North Chicago-based drugmaker AbbVie has pulled the plug on its plan to buy Dublin-based Shire, recommending shareholders vote against the planned $55 billion takeover following new U.S. tax rules. Shire stands to be paid a break-up fee of about $1.64...
  • Magnetic stimulation gains in depression treatment

     Magnetic stimulation gains in depression treatment
    A machine that sends magnetic pulses into a patient's brain has become the new frontier of depression treatment, promising to ease symptoms for those who have found little relief from medication or talk therapy. The treatment, known as transcranial...
  • AbbVie reconsiders its option with Shire

     AbbVie reconsiders its option with Shire
    AbbVie's surprise announcement late Tuesday that it is having second thoughts about its proposed acquisition of Shire raises numerous questions about the future of the deal. The North Chicago-based drugmaker said its board of directors will take...